Ledger.Open graph →
SEC Form D · Amendment · filed May 3, 2010

Esperance Pharmaceuticals, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
—
Industry
Biotechnology
Location
Baton Rouge, LA
Type
—

People & firms on this filing (10)

Hector Alila · Baton Rouge, LAExecJoseph Lovett · Baton Rouge, LADirectorRichard Babb · Baton Rouge, LAExecRoss Barrett · Baton Rouge, LADirectorChad Souvignier · Baton Rouge, LADirectorChristopher B. Knell · Plymouth Meeting, PAExecRalph L. Macdonald · Plymouth Meeting, PADirectorRobert Fesnak · Blue Bell, PADirectorJoseph Rindler · Blue Bell, PADirectorMichael Maher · Blue Bell, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗